ALLY in fighting COVID-19: magnitude of albumin decline and lymphopenia (ALLY) predict progression to critical disease

The global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic leading to coronavirus disease 2019 (COVID-19) is straining hospitals. Judicious resource allocation is paramount but difficult due to the unpredictable disease course. Once hospitalized, discerning which patients may p...

Descripción completa

Detalles Bibliográficos
Autores principales: van Zyl, Johanna S, Alam, Amit, Felius, Joost, Youssef, Ronnie M, Bhakta, Dipesh, Jack, Christina, Jamil, Aayla K, Hall, Shelley A, Klintmalm, Göran B, Spak, Cedric W, Gottlieb, Robert L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802390/
https://www.ncbi.nlm.nih.gov/pubmed/33431604
http://dx.doi.org/10.1136/jim-2020-001525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802390/
https://www.ncbi.nlm.nih.gov/pubmed/33431604
http://dx.doi.org/10.1136/jim-2020-001525

Ejemplares similares